WeChat
Weibo
Channel
Company News
Company News 2025-10-22
FIMAN Wins “2025 China Medical Aesthetic Device Annual Brand Enterprise” at MCC Golden Quality Awards
From October 21-22, 2025, the MCC Annual Ceremony and the 4th International Medical Aesthetic Device Conference was successfully held at the Shanghai Fuyue Hotel.
Themed "Technology as the Foundation, Global Co-creation," the event aimed to establish a hub for innovation in the medical aesthetic industry. Its mission is to continuously promote the industrialization, scaling, and globalization of high-end medical aesthetic devices, accelerating the global exploration and implementation of China's medical aesthetic industry across all sectors.
During the forum titled "The Post-Registration Era: Breaking Through Commercialization from Certification to Profitability," Li Hongqiang, Assistant Director of Medical/R&D at FIMAN, was invited to deliver a keynote speech on "Active Collagen: From Filling to Nutritional Regeneration." He shared Fiman's R&D breakthroughs and application prospects in the field of active collagen technology, offering forward-thinking insights and practical references for the commercialization pathway of collagen.
Themed "Technology as the Foundation, Global Co-creation," the event aimed to establish a hub for innovation in the medical aesthetic industry. Its mission is to continuously promote the industrialization, scaling, and globalization of high-end medical aesthetic devices, accelerating the global exploration and implementation of China's medical aesthetic industry across all sectors.
During the forum titled "The Post-Registration Era: Breaking Through Commercialization from Certification to Profitability," Li Hongqiang, Assistant Director of Medical/R&D at FIMAN, was invited to deliver a keynote speech on "Active Collagen: From Filling to Nutritional Regeneration." He shared Fiman's R&D breakthroughs and application prospects in the field of active collagen technology, offering forward-thinking insights and practical references for the commercialization pathway of collagen.
During the MCC Annual Ceremony, the winners of the "MCC 2025 China Medical Aesthetic Device Annual 'Golden Quality Award'" were officially announced. This award series was jointly initiated by the MCC 2025 Organizing Committee, along with representatives from hospitals, institutions, investors, and enterprises. It aims to build a strong brand image for medical aesthetic devices, inspire a sense of responsibility within the industry, and collectively empower the procurement decisions of hospitals and institutions while supporting the globalization of domestic medical aesthetic devices.
Leveraging its outstanding innovation and significant contributions to China's medical aesthetic device sector, FIMAN stood out in the "Golden Quality Award" selection and was honored as the "2025 China Medical Aesthetic Device Annual Brand Enterprise." Moving forward, FIMAN will continue to set a benchmark for quality, drive the high-quality development of the industry, and bring the excellence of national manufacturing to the global stage.